N'-[2-(4-Fluorophenoxy)ethanimidoyl]-2-phenoxypyridine-3-carbohydrazide

Catalog No. :
ACVKBK573
CAS No. :
337928-94-6
Molecular Formula :
C20H17FN4O3
Molecular Weight :
380.38

IUPAC Name:(Z)-2-(4-fluorophenoxy)-N'-(2-phenoxynicotinoyl)acetohydrazonamide

N'-[2-(4-Fluorophenoxy)ethanimidoyl]-2-phenoxypyridine-3-carbohydrazide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN'-[2-(4-Fluorophenoxy)ethanimidoyl]-2-phenoxypyridine-3-carbohydrazide
IUPAC Name(Z)-2-(4-fluorophenoxy)-N'-(2-phenoxynicotinoyl)acetohydrazonamide
MDL No.MFCD00173118
Molecular FormulaC20H17FN4O3
Molecular Weight380.38
SMILESO=C(C1=CC=CN=C1OC2=CC=CC=C2)NNC(COC3=CC=C(F)C=C3)=N
InChI KeyLWUOWKBITMYKMJ-UHFFFAOYSA-N
SynonymN'-[2-(4-fluorophenoxy)ethanimidoyl]-2-phenoxypyridine-3-carbohydrazide;3-Pyridinecarboxylic acid, 2-phenoxy-, 2-[2-(4-fluorophenoxy)-1-iminoethyl]hydrazide
CAS No.337928-94-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACVKBK573 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIZPQ256 route compound structure diagram
    ACIZPQ25624115-20-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVKBK573 route product structure diagram
    ACVKBK573337928-94-6
Inquiry

2. ACVKBK573 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHZPO809 route compound structure diagram
    ACHZPO80935620-71-4 In Stock
  4. Then
  5. ACVKBK573 route product structure diagram
    ACVKBK573337928-94-6
Inquiry

Comments (0)